- Reaction score
- 1,132
They abandoned hair, and focused on skin ?
Nope, their tech always had those three targets, hair, skin and tendon
They abandoned hair, and focused on skin ?
Nope, their tech always had those three targets, hair, skin and tendon
Does anyone know the news?
They are expected to announce the results in July and September, and now they are expected to make the announcement in September and October.
Does anyone know the news?
They are expected to announce the results in July and September, and now they are expected to make the announcement in September and October.
They abandoned hair, and focused on skin ?
Is it true that Japan can only treat 1,000 Japanese people if it is released conditionally in 2018?
A guy on HairLossTalk wrote this: „Under current Japanese law, cell treatments may receive conditional release after the completion of phase I or II clinical trials.No info yet, I think
Additionally, it is not certain yet whether Shiseido will opt for RCH-01 commercialization or not.
That’s the reality check for now.“
You will find your answers here:What do you mean? When will the Phase II Trials of Replicel start ?
When Shiseido will give us the Phase II results in October 18 will it be possible that the Trials in Germany of Replicel starts directly after that?
like the wise lizard allready explained @br1What do you mean? When will the Phase II Trials of Replicel start ?
When Shiseido will give us the Phase II results in October 18 will it be possible that the Trials in Germany of Replicel starts directly after that?
RepliCel is excited to have been chosen to present at next year's EBD Biotech Showcase in San Francisco January 7-9, 2019. Hope to see you there!
——
I assume no news of RCH-01 unfortunately... but let’s see
Well there is 13 of January today. Nothing new, no info at all :/